🔎 Trials Near Me

Home › Inflammatory Bowel Disease › NCT07195123

Evaluation of the SMART IBD App in Pediatric IBD

Recruiting

Evaluation of the SMART IBD App Digital Therapeutic Tool for Pediatric Inflammatory Bowel Disease

Who can join

Ages 13 to 17 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Confirmed diagnosis of IBD (Crohn's Disease, ulcerative colitis, or indeterminate colitis)
* Prescribed at least one daily or weekly medication for treatment of IBD
* \<86% adherence to prescribed medication
* Access to internet via Wi-Fi or data plan and access to smartphone
* English fluency for patient and caregiver

Exclusion Criteria:

* Diagnosis of pervasive developmental disorder in patient or caregiver as determined by medical chart review
* Diagnosis of serious mental illness (e.g., schizophrenia) in patient or caregiver as determined by medical chart review

About the study

The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The investigators will conduct a randomized control trial to compare 35 youth (ages 13-17) with IBD using an app that contains daily symptom diaries, education content, medication reminders, as well as monthly engagement challenges to 35 youth in an attention control group that will complete daily diaries. The length of the intervention will include one month of baseline symptom and adherence collection, a baseline assessment, 5 months of intervention, and a post-treatment assessment.

What is being tested

Sponsor: Children's Hospital Medical Center, Cincinnati · Participants: 70 · Started: Oct 23, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07195123

Locations in the U.S.

OhioCincinnati Children's Hospital Medical Center, Cincinnati

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.